ES2149791T3 - Procedimiento para la inactivacion de virus en preparaciones de proteinas. - Google Patents

Procedimiento para la inactivacion de virus en preparaciones de proteinas.

Info

Publication number
ES2149791T3
ES2149791T3 ES93106848T ES93106848T ES2149791T3 ES 2149791 T3 ES2149791 T3 ES 2149791T3 ES 93106848 T ES93106848 T ES 93106848T ES 93106848 T ES93106848 T ES 93106848T ES 2149791 T3 ES2149791 T3 ES 2149791T3
Authority
ES
Spain
Prior art keywords
procedure
viruses
inactivation
protein preparations
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93106848T
Other languages
English (en)
Other versions
ES2149791T5 (es
Inventor
Hermann Keuper
Walter Matzmorr
Wilfried Freudenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25915149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2149791(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Application granted granted Critical
Publication of ES2149791T3 publication Critical patent/ES2149791T3/es
Publication of ES2149791T5 publication Critical patent/ES2149791T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32661—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA INVENCION TRATA DE UN PROCEDIMIENTO PARA INACTIVAR LOS VIRUS EN UN SOLUCION DE PROTEINAS A TRAVES DE CALENTAMIENTO DE LA SOLUCION DURANTE PEQUEÑOS INTERVALOS DE TIEMPO.
ES93106848T 1992-05-26 1993-04-28 Procedimiento para la inactivacion de virus en preparaciones de proteinas. Expired - Lifetime ES2149791T5 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4217355 1992-05-26
DE4217355 1992-05-26
DE4240103A DE4240103A1 (de) 1992-05-26 1992-11-28 Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen
DE4240103 1992-11-28

Publications (2)

Publication Number Publication Date
ES2149791T3 true ES2149791T3 (es) 2000-11-16
ES2149791T5 ES2149791T5 (es) 2005-05-16

Family

ID=25915149

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93106848T Expired - Lifetime ES2149791T5 (es) 1992-05-26 1993-04-28 Procedimiento para la inactivacion de virus en preparaciones de proteinas.

Country Status (8)

Country Link
EP (1) EP0571771B2 (es)
JP (1) JP3650410B2 (es)
KR (1) KR940005805A (es)
AT (1) ATE194648T1 (es)
AU (1) AU3876793A (es)
CA (1) CA2096888C (es)
DE (2) DE4240103A1 (es)
ES (1) ES2149791T5 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19720853A1 (de) 1997-05-17 1998-11-19 Dade Behring Marburg Gmbh Erhöhung der FVII Empfindlichkeit eines Thromboplastinreagenzes
NL1016029C2 (nl) * 2000-08-28 2002-03-01 Gelatine Smits Beheer B V Werkwijze om ziekteveroorzakers uit te schakelen onder toepassing van verhitting.
BR0115584A (pt) * 2000-11-24 2003-09-23 Breath Ltd Esterilização de produtos farmacêuticos
CN107438663A (zh) * 2015-04-20 2017-12-05 通用电气医疗集团生物科学公司 病毒灭活
US11052165B2 (en) 2015-04-20 2021-07-06 Global Life Sciences Solutions Usa Llc Method for virus clearance
US10047596B2 (en) 2015-07-23 2018-08-14 General Electric Company System and method for disposal of water produced from a plurality of wells of a well-pad
US10323494B2 (en) 2015-07-23 2019-06-18 General Electric Company Hydrocarbon production system and an associated method thereof
US10077646B2 (en) 2015-07-23 2018-09-18 General Electric Company Closed loop hydrocarbon extraction system and a method for operating the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124506B1 (de) * 1983-05-02 1988-08-17 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Inaktivierung von vermehrungsfähigen Krankheitserregern
US4695454A (en) * 1985-04-01 1987-09-22 New York Blood Center, Inc. Process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
DE3905066A1 (de) * 1989-02-18 1990-08-23 Behringwerke Ag Waermetauschermodul
FR2664165B1 (fr) * 1990-07-03 1992-10-16 Lille Transfusion Sanguine Composition pour stabiliser le plasma sanguin en cours de pasteurisation.

Also Published As

Publication number Publication date
ATE194648T1 (de) 2000-07-15
EP0571771A2 (de) 1993-12-01
CA2096888C (en) 2004-04-27
AU3876793A (en) 1993-12-02
JPH0665091A (ja) 1994-03-08
ES2149791T5 (es) 2005-05-16
EP0571771B1 (de) 2000-07-12
EP0571771A3 (en) 1994-07-06
CA2096888A1 (en) 1993-11-27
JP3650410B2 (ja) 2005-05-18
KR940005805A (ko) 1994-03-22
DE4240103A1 (de) 1993-12-02
EP0571771B2 (de) 2004-10-20
DE59310073D1 (de) 2000-08-17

Similar Documents

Publication Publication Date Title
ES552985A0 (es) Procedimiento fotodinamico de inactivacion de virus
DE69331762D1 (de) "heat shock"-proteine und behandlung von tumoren
NO955291D0 (no) System for viral inaktivering av blod
DE59108923D1 (de) Photochemisches Stabilisieren von Wolle
ES2113347T3 (es) Procedimiento para la desactivacion de virus en sangre y en productos de sangre.
DE69331316D1 (de) Verwendung von protease-inhibitoren als antiviral agentien
ATE33558T1 (de) Stabilisierung von influenzavirusimpfstoffen.
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
ES2149791T3 (es) Procedimiento para la inactivacion de virus en preparaciones de proteinas.
ATE49882T1 (de) Sebosuppressive kosmetische mittel, enthaltend benzylalkohol-derivate.
BR9300524A (pt) Composicao para estabilizar o plasma sanguineo durante a pasteurizacao e solucao plasmatica prasteurizada de uso terapuetico
FI953756A7 (fi) Menetelmä lipidivaipattomien virusten inaktivoimiseksi
ES2159287T3 (es) Peptidos hemorreguladores.
ES8800358A1 (es) Un procedimiento para preparar un polipeptido hibrido.
FI880636A7 (fi) Menetelmä vaipallisten virusten inaktivoimiseksi solun avulla in vitro valmistetuissa proteiinivalmisteissa.
ES507444A0 (es) Procedimiento para inactivar virus de la fiebre aftosa.
DE69522685D1 (de) Behandlung von blut-plasma
DK412286A (da) 4-acylaminobenzamid-derivater, fremgangsmaade til fremstilling heraf samt mellemprodukter til brug ved fremgangsmaaden
DE58907891D1 (de) Verfahren zur Sterilisation von intraocularen Linsen.
DK530788A (da) Anvendelse af praeparater til desinfektion af afstoebninger
DK0579765T3 (da) Fremgangsmåde og præparat til behandling af herpes-relaterede sygdomme
ES2055132T3 (es) Polipeptidos recombinantes del virus de la septicemia hemorragica de los peces.
ITRM920216A1 (it) Set per soluzione salina sterile ad uso chirurgico.
DK0378107T3 (da) Fremgangsmåde til fremstilling af virusfrie naturstoffer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 571771

Country of ref document: ES